Multiple sclerosis: New help, new hope

David C Hess, Mary D. Hughes

Research output: Contribution to journalReview article

Abstract

Immunomodulatory agents reduce the rate of relapse in patients with relapsing-remitting multiple (MS); in addition, these drugs, particularly the interferons, can slow the progression of the disease. Thus, early treatment can help prevent disability. High doses of corticosteroids given early during an MS relapse may decrease the length and severity of the attack. Mitoxantrone is generally reserved for patients with progressive forms of MS who are experiencing rapid loss functioning. Consider intravenous immunoglobulin for patients who have had steady disease progression. Combinations of either an interferon or glatiramer with oral immunosuppresant or pulse corticosteroid therapy are increasingly used.

Original languageEnglish (US)
Pages (from-to)1144-1148
Number of pages5
JournalConsultant
Volume45
Issue number10
StatePublished - Sep 1 2005

Keywords

  • Immunomodulatory therapy
  • Multiple sclerosis
  • Rehabilitation

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Multiple sclerosis: New help, new hope'. Together they form a unique fingerprint.

  • Cite this

    Hess, D. C., & Hughes, M. D. (2005). Multiple sclerosis: New help, new hope. Consultant, 45(10), 1144-1148.